2009 Annual Meeting | Epilepsy Therapy

Date Thursday 04/30/09

Time 07:00 PM - 09:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Therapy Program

Director(s) Susan T. Herman, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the best therapeutic options available for the management of new-onset epilepsy, generalized epilepsy, and intractable partial epilepsy; be able to choose the optimal antiepileptic drug for an individual patient based on seizure type and epilepsy syndrome; develop treatment plans for special populations with epilepsy such as children, women, and older adults; recognize the common acute and chronic adverse effects of antiepileptic drugs; discuss the timing of referral of patients for epilepsy surgical evaluation or implantation of the vagus nerve stimulator; apply evidence-based approaches to the management of epilepsy; and recognize areas of controversy and uncertainty.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
07:00 PM - 07:35 PM		Management of the First Seizure and Newly Diagnosed Epilepsy Susan T. Herman, MD, FAAN
07:00 PM - 09:00 PM		Reception
07:35 PM - 08:10 PM		Treatment of Generalized Epilepsies: Idiopathic and Symptomatic Gregory K. Bergey, MD, FAAN
08:10 PM - 08:45 PM		Intractable Partial Epilepsy: Antiepileptic Drug and Surgical Options Maromi Nei, MD
08:45 PM - 09:00 PM		Questions and Answers

Faculty Disclosures
Gregory K. Bergey, MD, FAAN	Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics.
Susan T. Herman, MD, FAAN	The institution of Dr. Herman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. The institution of Dr. Herman has received research support from Neuroelectrics, Inc. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities.
Maromi Nei, MD	No disclosure on file

��ɫ��

��ɫ��